LEDAGA

recordati rare diseases canada inc🇨🇦 Health Canada

Approval Id: a505c1d4edab894d
Drug Approval Canada Name: LEDAGA
Product Name: LEDAGA
Status: Marketed
Status Date: 2022-09-14
Original Market Date: 2022-09-14
Din: 02516764
Drug Class: Human
Dosage Form: Gel
Route Of Administration: Topical
Schedule: Prescription
Ahfs: 10:00.00
Atc Original: L01AA05 CHLORMETHINE
Atc Name: l 01 aa 05
Aig Number: 0107722002
Company Name: recordati rare diseases canada inc
Company Address: 3080 Yonge Street, Suite 6060, Toronto, Ontario, Canada, M4N 3N1

CHLORMETHINE (CHLORMETHINE HYDROCHLORIDE)

160 MCG / G

Authorized

Agency

Health Canada

Country

🇨🇦

Approval Date

Jul 4, 2025

Approval ID

a505c1d4edab894d

Type

Standard